Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
23 Jun 2021, 17:00:35 UTC
Prior SEC filing
17 Jun 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Takeshi Yamamoto, President and CEO of FUJIFILM Cellular Dynamics, Inc. and attorney-in-fact for FUJIFILM Holdings America Corporation, FUJIFILM Corporation and FUJIFILM Holdings Corporation

Key filing fact

FUJIFILM Cellular Dynamics, Inc. filed Form 4 for Century Therapeutics, Inc. (IPSC) on 23 Jun 2021.

Key facts

  • This page summarizes FUJIFILM Cellular Dynamics, Inc.'s Form 4 filing for Century Therapeutics, Inc. (IPSC).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 23 Jun 2021, 17:00.

Change

  • Previous filing in this sequence was filed on 17 Jun 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IPSC transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+3,974,404
Change %
+133%
Price
Shares after
6,955,207
Date
22 Jun 2021
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IPSC transaction Derivative

Series A Convertible Preferred Stock

Conversion of derivative security

Transaction value
$0
Shares
-10,000,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
22 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,974,404
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering.

Footnote F2

FUJIFILM Cellular Dynamics, Inc. is the direct owner of the reported securities. FUJIFILM Cellular Dynamics, Inc. is a wholly owned subsidiary of FUJIFILM Holdings America Corporation; FUJIFILM Holdings America Corporation is a wholly owned subsidiary of FUJIFILM Corporation; and FUJIFILM Corporation is a wholly owned subsidiary of FUJIFILM Holdings Corporation. Accordingly, each of FUJIFILM Holdings America Corporation, FUJIFILM Corporation and FUJIFILM Holdings Corporation beneficially owns the reported securities indirectly.

SEC remarks

Exhibit List: Exhibit 99 - Joint Filer Information

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .